Incidence rate of ovarian cancer in Iran in comparison with developed countries

Indian Journal of Cancer

Volumn 47, Issue 3, 2010, Pages 322-327

  Arab, M ^a   Khayamzadeh, M ^a   Tehranian, A ^b   Tabatabaeefar, M ^a   Hosseini, M ^a   Anbiaee, R ^a   Golfam, F ^c   Akbari, M ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Incidence; Iran; Ovarian cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; DEVELOPED COUNTRY; FAT INTAKE; FEMALE; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; NEWBORN; OVARY CANCER;

ADULT; AUSTRALIA; CARCINOMA; DEVELOPED COUNTRIES; FEMALE; HUMANS; INCIDENCE; IRAN; MIDDLE AGED; OVARIAN NEOPLASMS; REGISTRIES; UNITED STATES;

EID: 77954447126     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.64721     Document Type: Article

References (42)

1. National cancer institute 2005. SEER cancer statistics review (1975-2002). Ovarian epithelial cancer (PDG): Treatment-Health professionals. J National Cancer Institute. Vol 98. Available from: http://www.cancer.gov. [last accessed on 2006 Aug 19].
2. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001;94:153-156
3. Akbari ME, Khayamzadeh M. Incidence, mortality and burden of cancers in Iran. In: Akbari ME, editor. Iran cancer report. 1st ed. Tehran: Cancer Research Center, Shahid Beheshti University of Medical Sciences; 2008. p. 95-125.
4. Arab M, Khayamzadeh M, Mohit M, Hosseini M, Anbiaee R, Tabatabaeefar M, et al. Survival of ovarian cancer in Iran: 2000-2004. Asian Pac J Cancer Prev 2009;10:555-558
5. Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: cross- sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005;113:977-990
6. Primic-Zakelj M, Zadnik V, Zagar T. Is cancer epidemiology different in Western Europe to that in Eastern Europe? Ann Oncol 2005;16:ii27-9.
7. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer 2002;100:86-91.
8. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med 2009;12:15-23.
9. Cancer office, Health Deputy. Table of numbers and percentages of cancers according to histology result. Cancer office, Health Deputy. Iranian Annual of National cancer registration report. 1st ed. Tehran: Islamic Republic of Iran, Ministry of Health and Medical Education, center for disease control and prevention; 2005-2006. p. 241-243
10. Scully RE, Young RH, Clement PB. General aspects and classification. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. In: Scully RE, editor. Atlas of tumor pathology, third series. Washington DC: Armed forces institute of pathology; 1998. p. 30-48.
11. Scully RE. Histological classification of ovarian tumours. In: Scully RE, editor. Ovarian Tumors. 2nd ed. Berlin: Springer -Verlag; 1999. p. 100-120
12. Berg JW. Morphologic classification of human cancer. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. 2nd ed. New York: Oxford; 1996. p. 28-44.
13. Quirk JT, Natarajan N, Mettlin CJ. Age- specific ovarian cancer incidence rate patterns in the united states 2005; Gynecol Oncol 2005;99:248-250
14. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005;97:519-523
15. Available from: http://www.Census.gov/ipc/www/idb/ worldpopinfo.html. [last accessed in 2009]
16. Available from: http://www.seer.cancer.gov/statfacts/html/ ovary.html. [last accessed in 2009].
17. Available from: http://www.cancer-rates.Info/naaccr. [last accessed in 2009].
18. Available from: http://www.wonder.cdc.gov/controller/ datarequest/D40. [last accessed in 2009].
19. Available from: http://www.aihw.gov.au/cancer/data/excel- tables/index.cfm. [last accessed in 2009].
20. Australian institute of Health and welfare (AIHW) and National Breast cancer center (NBCC) 2006, ovarian cancer in Australia: An overview, 2006. Available from: http://www.aihw.gov.au/ publications/can/oca06/oca06.pdf [last accessed in 2009].
21. Laurvick CL, Semmens JB, Holman CD, Leung YC. Ovarian cancer in Western Australia (1982-1998): Incidence, mortality and survival. Aust N Z J Public Health 2003;27:588-595
22. Skírnisdóttir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960-2005: Trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 2008;123: 1897-1901
23. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL, et al. A case control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654-661
24. Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005;113:977-990
25. Hirabayashi Y, Marugame T. Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol 2007;39:860-861
26. Negri E, Franceschi S, Tzonou A, Booth M, La Vecchia C, Parazzini F, et al. Pooled analysis of 3 European case-control studies: I, reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991;49:50-56
27. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994;344:1250-1254
28. Chiaffarino F, Pelucchi C, Parazzini F, Negri E, Franceschi S, Talamini R, et al. Reproductive and hormonal factors and ovarian cancer. Ann Oncol 2001;12:337-341
29. Parazzini F, Franceschi S, La Vecchia C, Fasoli M. The epidemiology of ovarian cancer. Gynecol Oncol 1991;43:9-23.
30. Franceschi S, Parazzini F, Negri E, Booth M, La Vecchia C, Beral V, et al. Pooled analysis of 3 European case control studies of epithelial ovarian cancer: III, Oral contraceptive use. Int J Cancer 1991;49:61-65
31. Simon WE, Albrecht M, Hänsel M, Dietel M, Hölzel F. Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 1983;70: 839-845
32. Whittemore AS, Harris R, Itnyre J; Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II: Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:184-203.
33. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility and the risk of epithelial ovarian cancer. Am J Epidemiol 1994;140: 585-597
34. Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives-Findings in a large cohort study. Br J Cancer 1995;71:1340-1342
35. La Vecchia C, Franceschi S. Oral contraceptives and ovarian cancer. Eur J Cancer Prev 1999;8:297-304.
36. WHO. Hormonal contraception and post-menopausal hormonal therapy. WHO. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol-72. Lyon: IARC; 1999. p. 156-168
37. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, et al. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer 2002;102:262-265
38. Bosetti C, Negri E, Franceschi S, Pelucchi C, Talamini R, Montella M, et al. Diet and ovarian cancer risk: a case-control study in Italy. Int J Cancer 2001;93:911-915 (Pubitemid 32756764)
39. La Vecchia C, Decarli A, Negri E, Parazzini F, Gentile A, Cecchetti G, et al. Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst 1987;79:663-669 (Pubitemid 17146828)
40. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670-3674
41. Bidoli E, La Vecchia C, Montella M, Maso LD, Conti E, Negri E, et al. Nutrient intake and ovarian cancer: an Italian case-control study. Cancer Causes Control 2002;13:255-261
42. Bosetti C, Negri E, Franceschi S, Talamini R, Montella M, Conti E, et al. Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy). Cancer Causes Control 2002;13:465-470